a separate treatment-use formulation (0.5 mg and 1.0 mg base per vial, for treating growth hormone deficiency and growth failure in children) was approved September 26, 1997 under NDA 20-443
Key Features Research-Grade Purity Manufactured to high-quality standards for laboratory use 10MG Concentration Precise dosing for controlled experiments Nasal Spray Delivery Non-invasive and efficient administration method Stable Formulation Designed for consistency and reliability in research settings Neuropeptide Classification Studied in neuroscience and sleep research models Potential Research Applications Sleep cycle and slow-wave (delta) sleep studies Circadian rhythm and sleep-wake regulation models Stress response and HPA axis research Neuroendocrine signaling and hormonal balance studies Cognitive recovery and neurological research DSIP is commonly used in experimental models to explore how peptide signaling affects sleep quality, stress adaptation, and overall physiological equilibrium

The comprehensive GHK-Cu peptide for hair guide covers application methods and protocols in detail, while the broader copper peptides GHK-Cu guide explains the full range of tissue-repair benefits
Under stress, MOTS-C translocates to the nucleus for direct gene regulation a dual-compartment mechanism unique among metabolic peptides
It is effective against dullness, dark spots, and early signs of pigmentation